IFNG and neoplasm: While TAMs from TC-1/A9 tumors, which were stimulated with an IFN-γ + TLR agonist to the anti-tumor M1 phenotype, inhibited the proliferation of TC-1/A9 cells, TAMs from the TC-1/dB2m tumors hardly affected the proliferation of TC-1/dB2m cells.